Mictonorm

Propiverine Hydrochloride, the active ingredient in Mictonorm, is an antimuscarinic presented as an oral tablet for oral use. It treats overactive bladder symptoms such as urgency, frequency, and urge urinary incontinence in adults.

GNH USA supplies Mictonorm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Propiverine Hydrochloride is used to manage overactive bladder, a condition characterized by involuntary detrusor contractions.

- Overactive bladder: reduces urgency episodes and increases bladder capacity. - Urinary urgency: alleviates sudden, compelling urge to void. - Urinary frequency: decreases the number of daily voids. - Urge urinary incontinence: helps control involuntary leakage.

Propiverine Hydrochloride may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Dry mouth - Constipation - Blurred vision - Headache - Dizziness - Nausea

Serious or Rare Side Effects: - Urinary retention - Severe allergic reaction (anaphylaxis) - Angle‑closure glaucoma - Tachycardia - Severe constipation leading to obstruction - Elevated liver enzymes

Before initiating therapy, several safety considerations should be reviewed.

- Renal function assessment: adjust use in impaired patients. - Monitor for urinary retention: especially in those with pre‑existing obstruction. - Caution in glaucoma: avoid in patients with narrow‑angle disease. - Review anticholinergic load: limit concurrent antimuscarinic drugs. - Hypersensitivity: discontinue if allergic reaction occurs. - Store at below 25°C: keep in the original pack, protect from moisture.

Propiverine may interact with other medicines, requiring attention to the level of interaction.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase plasma levels. - Other antimuscarinic agents: additive anticholinergic effects. - Medications that cause urinary retention (e.g., certain antihistamines): heightened risk of retention.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampicin, carbamazepine): may reduce efficacy. - Diuretics: monitor fluid balance and electrolytes. - Antihistamines with anticholinergic activity: observe for enhanced side effects.